UNSPSC 51393700: Sympathomimetic or adrenergic pyrimidines

This classification denotes aympathomimetic or adrenergic drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.

UNSPSC 51393700 Sympathomimetic or adrenergic pyrimidines is a Class code that encompasses pharmaceutical procurement by state and local health agencies, though recent activity under this code shows a significant mismatch between the nominal scope and actual buying patterns. The recent opportunities posted under this code include naloxone (an opioid antagonist, not a sympathomimetic pyrimidine) and a request for information on direct-to-manufacturer prescription programs, neither of which aligns closely with the abstract code name. State and local health departments, county public health systems, and state HHS commissions are the primary issuing bodies using this code for pharmaceutical purchases supporting community health initiatives and pharmacy benefit program modernization.

Activity under this code remains sparse in the recent-opportunities dataset. Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. The Texas Health and Human Services Commission issued a Request for Information (RFI No. HHS0017013) posted April 3, 2026 to gather vendor capabilities on implementing a direct-to-manufacturer prescription program for self-insured employee and state agency health plans. Florida and Texas are the primary states represented in recent postings. The mismatch between the code's nominal pharmaceutical classification and the actual work being solicited—opioid antagonists, drug deactivation systems, and pharmacy benefit program infrastructure—suggests either miscoding in the procurement notices or a disconnect between UNSPSC taxonomy and current state and local health procurement practice.